Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 3 I, 1998, Pages 758-761

  Casey, B M ^a   Bawdon, R E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Ex vivo; Placental transfer; Protease inhibitor

Indexed keywords

RITONAVIR; ZIDOVUDINE;

ARTICLE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG CLEARANCE; FEMALE; FETUS CIRCULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRIORITY JOURNAL; VERTICAL TRANSMISSION;

EID: 0031670263     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70078-X     Document Type: Article

References (19)

1. P Duff HIV infection in women Primary Care Update Ob/Gyn 3 1996 45 49
2. P Van de Perre A Simonon P Msellati DG Hitimana D Vaira A Bazubagira Postnatal transmission of human immunodeficiency virus type I from mother to infant N Engl J Med 325 1991 593 598
3. JB Zeigler Breast feeding and HIV Lancet 342 1993 1437 1438
4. DT Dunn ML Newell AE Ades CS Peckham Risk of human immunodeficiency virus type 1 transmission through breastfeeding Lancet 340 1992 585 588
5. EM Connor RS Sperling R Gelber P Kiselev G Scott MJ O’Sullivan Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment N Engl J Med 331 1994 1173 1180
6. RE Dickover EM Garratty SA Herman MS Sim S Plaeger PJ Boyer Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission JAMA 275 1996 599 605
7. H Minkoff M Augenbram Antiretroviral therapy for pregnant women Am J Obstet Gynecol 176 1997 478 489
8. CJ Carpenter MA Fischl SM Hammer MS Hirsch DA Jacobsen DA Katzenstein Antiretroviral therapy for HIV infection in 1997 JAMA 277 1997 1962 1969
9. JA Lipsky Antiretroviral drugs for AIDS Lancet 348 1996 800 803
10. JE Gallant The Johns Hopkins AIDS Service Hopkins HIV Rep 8 1996 1 4
11. VS Kitchen C Skinner K Ariyoshi EA Lane IB Duncan J Burckhardt Safety and activity of saquinavir in HIV infection Lancet 345 1995 952 955
12. M Markowitz M Saag WG Powderly AM Hurley A Hsu JM Valdes A preliminary study of ritonavir, an inhibitor of HIV-1 proteases, to treat HIV-1 infection N Engl J Med 333 1995 1534 1539
13. SA Danner A Carr JM Leonard LM Lehman F Gudiol J Gonzales A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease N Engl J Med 333 1995 1528 1533
14. RE Bawdon S Sobhi J Dax The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta Am J Obstet Gynecol 167 1992 1570 1574
15. L Liebes S Mendoza D Wilson J Dancis Transfer of zidovudine (AZT) by human placenta J Infect Dis 161 1990 203 207
16. DH Watts ZA Brown T Tartaglione SK Burchett K Opheim R Coombs Pharmacokinetic disposition of zidovudine during pregnancy J Infect Dis 163 1991 226 232
17. JC Challier Criteria for evaluating perfusion experiments and presentation of results Contrib Gynecol Obstet 13 1985 32 39
18. RS Sperling DE Shapiro RW Coombs JA Todd SA Herman GD McSherry Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type I from mother to infant N Engl J Med 335 1996 1621 1629
19. Panel on Clinical Practices for Treatment of HIV Infection Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents MMWR Morb Mortal Wkly Rep 47 RR-5 1998 43 82